Author:
Egeter Jonas,Wintner Lisa M.,Huber Nathalie,Rumpold Gerhard,Sperner-Unterweger Barbara,Bliem Harald R.,Holzner Bernhard
Funder
University of Innsbruck and Medical University of Innsbruck
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Federal Drug Administration, US Department of Health and Human Services, Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims, Clin. Fed. Regist. (2009) 1–39. http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf (accessed November 16, 2016).
2. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader D, Fries JF, Bruce B, Rose M, PROMIS Cooperative Group (2007) The patient-reported outcomes measurement information system (PROMIS). Med Care 45:S3–S11. https://doi.org/10.1097/01.mlr.0000258615.42478.55
3. Khanna D, Maranian P, Rothrock N, Cella D, Gershon R, Khanna PP, Spiegel B, Furst DE, Clements PJ, Bechtel A, Hays RD (2012) Feasibility and construct validity of PROMIS and “legacy” instruments in an academic scleroderma clinic. Value Health 15:128–134. https://doi.org/10.1016/j.jval.2011.08.006
4. Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79. https://doi.org/10.1186/1477-7525-1-79
5. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes CJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe B, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献